Sterility Testing, Other Issues Lead to Warning Letter for Teva

Drug GMP Report
A A
Teva Pharmaceuticals has received a warning letter due to sterility testing and contamination issues at its plant in Godollo, Hungary.

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $40.00